- Home
- MLKN vs ELVN Comparison
MLKN vs ELVN Comparison
Compare MLKN & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLKN
- ELVN
- Stock Information
- Founded
- MLKN 1905
- ELVN 2016
- Country
- MLKN United States
- ELVN United States
- Employees
- MLKN N/A
- ELVN N/A
- Industry
- MLKN Office Equipment/Supplies/Services
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- MLKN Consumer Discretionary
- ELVN Health Care
- Exchange
- MLKN Nasdaq
- ELVN Nasdaq
- Market Cap
- MLKN 1.2B
- ELVN 1.2B
- IPO Year
- MLKN N/A
- ELVN 2020
- Fundamental
- Price
- MLKN $21.47
- ELVN $19.77
- Analyst Decision
- MLKN
- ELVN Strong Buy
- Analyst Count
- MLKN 0
- ELVN 5
- Target Price
- MLKN N/A
- ELVN $41.20
- AVG Volume (30 Days)
- MLKN 393.5K
- ELVN 327.6K
- Earning Date
- MLKN 09-18-2025
- ELVN 08-13-2025
- Dividend Yield
- MLKN 3.45%
- ELVN N/A
- EPS Growth
- MLKN N/A
- ELVN N/A
- EPS
- MLKN N/A
- ELVN N/A
- Revenue
- MLKN $3,669,900,000.00
- ELVN N/A
- Revenue This Year
- MLKN $4.74
- ELVN N/A
- Revenue Next Year
- MLKN $3.64
- ELVN N/A
- P/E Ratio
- MLKN N/A
- ELVN N/A
- Revenue Growth
- MLKN 1.14
- ELVN N/A
- 52 Week Low
- MLKN $15.25
- ELVN $13.30
- 52 Week High
- MLKN $30.56
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- MLKN 64.77
- ELVN 49.50
- Support Level
- MLKN $19.62
- ELVN $18.13
- Resistance Level
- MLKN $21.81
- ELVN $20.26
- Average True Range (ATR)
- MLKN 0.72
- ELVN 1.24
- MACD
- MLKN 0.18
- ELVN 0.01
- Stochastic Oscillator
- MLKN 90.16
- ELVN 59.11
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.